Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
New reviews show AI tools can help spot and manage kidney disease early.
Today's news focuses on how technology and body weight affect kidney health. The strongest evidence comes from a review showing that AI tools are useful for early detection. A large study also links extreme body weight to higher kidney disease risk in diabetics. Most other findings are preliminary or observational, so they show links but not definite causes.
Applications of artificial intelligence in chronic kidney disease: a systematic review.
This review looked at how computer tools help find and manage kidney disease. It checked studies from 2019 to 2025. The review shows these tools can spot problems early. It is a summary of many studies, so it is strong evidence.
Diagnostic accuracy of AI-augmented renal ultrasound for degenerative kidney disorders: a systematic review and meta-analysis.
This review looked at 18 studies and found AI added to kidney ultrasound correctly identified degenerative kidney disease in most cases — about 85% accurate for detecting scarring and 78% accurate for staging disease severity. The AI tools were tested on images from real patients, but no study yet shows this improves patient outcomes. A large randomized trial is needed to prove it helps people keep their kidneys longer.
Influence of Donor Age on Graft and Patient Outcomes in Kidney Transplantation: A Systematic Review and Meta-Analysis.
This study pooled earlier research to ask whether an older kidney donor means a worse result for the person who gets the kidney. The authors followed standard review rules (PRISMA 2020) and searched 4 major medical databases. It looked at how long the new kidney keeps working and how long patients live. The excerpt we have does not give the size of the effect, so read the full paper before drawing conclusions about older donor kidneys.
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease.
This review pooled 10 sets of randomized trial data from adults with type 2 diabetes and kidney disease. It compared four options for protecting the kidneys and heart: finerenone, SGLT2 inhibitor drugs, semaglutide, and finerenone taken with an SGLT2 inhibitor. It also compared their side effects. The part of the summary we received cuts off before the results, so we cannot yet say which option did best or by how much.
Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin
This study looked at 324 people with kidney disease who started a new drug combo. It checked how their kidney filtering rate changed in the first few weeks. The goal was to see if the drop in function was safe and expected.
From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX–Targeted [ 68 Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [ 18 F]FDG PET/CT
This trial compared two types of PET scans for kidney cancer in 68 people. It is a small randomized trial, so the results are promising but not definitive. The study looked at how well each scan found tumors. It helps doctors choose the best imaging test for kidney cancer patients.
Influence of Chronic Kidney Disease on Outcomes After Paclitaxel-Coated Balloon Angioplasty for Coronary In-Stent Restenosis
This study looked at people with kidney disease who had a heart procedure to open blocked arteries. It shows a link between kidney health and how well the heart procedure works. It is an observational study, so it shows a connection but not proof of cause.
Distinct renal adverse event profiles among CDK4/6 inhibitors: a comparative pharmacovigilance analysis
This study looked at safety reports for three cancer drugs. It found that each drug has a different pattern of kidney side effects. This shows a link between the drugs and kidney issues, but it is not proof of cause.
Epidemiology of Critically Ill Patients With Cirrhosis Undergoing Continuous Renal Replacement Therapy: A Contemporaneous Parallel Analysis of the HRS-HARMONY and CRRTnet Registries.
This study looked at 245 people with liver disease who needed dialysis in the ICU. It tracked how they were treated and how many died in the hospital. It shows a link between treatment choices and outcomes. It does not prove that one choice caused the result.
0055Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study
This study looked at people with hard-to-control high blood pressure. It checked if high stress hormone levels were linked to kidney function. It found that 27.3% had high stress hormone levels. It shows a link, not proof of cause.
Risk Factors and Short-Term Outcomes of Lower Limb Fractures in Diabetic Patients Presenting to Emergency
This study looked at 180 people with diabetes who broke a bone in their leg or arm. It found that diabetes can make healing harder after a break. This is an observational study, so it shows a link but not proof of cause. It helps doctors know what to watch for in diabetic patients with fractures.
Clinical and Medication-Related Factors Associated with Adverse Renal Outcomes in Advanced Chronic Kidney Disease Patients Treated with Empagliflozin: A Real-World Study in Thailand
This study followed people with advanced kidney disease who started taking empagliflozin. It looked at who had bad kidney outcomes after starting the drug. It is an observational study, so it shows a link, not proof of cause. The drug is known to be safe, but this study checks how it works in real life.
0077Aromatase Inhibitors Versus Tamoxifen and Cardiovascular-Kidney-Metabolic Stage Progression in Women with Breast Cancer: A Real-World Database Propensity-Matched Cohort Study
This study compared two breast cancer drugs in women. It looked at how they affect heart and kidney health over five years. It is an observational study, so it shows a link, not proof of cause. It helps doctors choose the safer option for heart and kidney health.
Impact of incremental peritoneal dialysis on long-term nutritional trajectories in end-stage kidney disease: a longitudinal cohort study
This study followed people on peritoneal dialysis to see how their nutrition changed over time. It looked at a specific dialysis method called incremental peritoneal dialysis. This is an observational study, so it shows a link between dialysis type and nutrition, but not proof of cause. It helps doctors plan better diet support for dialysis patients.
Age- and sex-specific associations of underweight and excess adiposity with incident CKD in type 2 diabetes: nationwide Korean cohort study
This study looked at 1,824,317 adults with type 2 diabetes in Korea. It found that being underweight or having too much body fat raises the risk of developing kidney disease. The risk depends on a person's age and sex. This shows a link, but it does not prove that weight changes cause the disease.
Frailty assessed using the Edmonton Frail Scale predicts mortality and waitlist removal for kidney transplant candidates: a prospective study
This study followed 279 people waiting for a kidney transplant. It found that a frailty score could predict who was at higher risk of dying or being removed from the list. This is an observational study, so it shows a link, not proof of cause.
Artificial Intelligence- Assisted Dosing Optimization in Renal Impairment Patients: A Retrospective Observational Study
This study checked if AI tools can help doctors pick the right drug doses for people with kidney disease. It is a retrospective observational study, meaning it looks back at past records. It shows a link between AI use and dosing, but not proof of cause. It suggests AI might help avoid drug side effects in kidney patients.
Integrating non-communicable disease screening to COVID-19 and human immunodeficiency virus care in Johannesburg South Africa: a pilot model for low- and middle-income countries
This study tested a way to check for chronic diseases in HIV clinics. It involved 461 people in South Africa. It shows that adding these checks can work in busy clinics. It is a pilot test, so it is a first step, not a final proof.
Albumin-Corrected Serum Calcium as a Biochemical Correlate of Left Ventricular Dysfunction Among Patients With End-Stage Renal Disease on Maintenance Hemodialysis: A Cross-Sectional Study
This study looked at people with kidney failure on regular hemodialysis (blood-cleaning treatment by machine). It checked whether their blood calcium level, adjusted for a blood protein called albumin, was tied to a weaker heart pump, meaning the main pumping chamber was not working well. It measured everyone at one point in time, so it can show a link but not proof that calcium causes heart problems. No abstract was available, so we could not check the numbers.
Clinical application of sugammadex in renal impairment: pharmacokinetics and pharmacodynamics
This article looks at sugammadex, a drug used after surgery to reverse muscle-relaxing medicines, in people whose kidneys do not work well. It covers how the body clears the drug and how well it works when the kidneys filter slowly. The title suggests it is a review of earlier studies, not a new trial, so it is weaker evidence. It may matter to people with kidney disease who are facing surgery. No abstract was available, so we could not check the details.